Abstract
Cardiovascular disease (CVD) begins early in the course of chronic kidney disease (CKD) and is the leading cause of death in patients with CKD. Preventing the development of CVD and establishing new clinical tools for identifying high-risk individuals, particularly those with an increased risk for cardiac death, is of clinical importance. Abnormality of heart rate variability (HRV) has been shown to be associated with CVD and CKD. Assessment of HRV is based on analysis of consecutive normal R–R intervals and may provide quantitative information on the modulation of cardiac vagal and sympathetic nerve input. In this brief manuscript, increased CVD risk among CKD patients, mechanisms due to autonomic nerves dysfunction, changes of HRV and potential measures to ameliorate clinical prognostic of CKD patients will be discussed.
Similar content being viewed by others
References
Meijers BK, Claes K, Bammens B et al (2010) p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin J Am Soc Nephrol 5:1182–1189
Mylonopoulou M, Tentolouris N, Antonopoulos S et al (2010) Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy. Nephrol Dial Transpl 25:3749–3754
Schiffrin EL, Lipman ML, Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116:85–97
Ondocin PT, Narsipur SS (2006) Influence of angiotensin converting enzyme inhibitor treatment on cardiac autonomic modulation in patients receiving haemodialysis. Nephrology (Carlton) 11:497–501
Mutsaers HA, van den Heuvel LP, Ringens LH et al (2011) Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations. PLoS ONE 6:e18438
Roumelioti ME, Ranpuria R, Hall M et al (2010) Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol Dial Transpl 25:3733–3741
Kojima M, Hayano J, Fukuta H et al (2008) Loss of fractal heart rate dynamics in depressive hemodialysis patients. Psychosom Med 70:177–185
Undem BJ, Kollarik M (2005) The role of vagal afferent nerves in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:355–360 (discussion 71–72)
Ranpuria R, Hall M, Chan CT, Unruh M (2008) Heart rate variability (HRV) in kidney failure: measurement and consequences of reduced HRV. Nephrol Dial Transpl 23:444–449
Chan CT (2008) Heart rate variability in patients with end-stage renal disease: an emerging predictive tool for sudden cardiac death? Nephrol Dial Transpl 23:3061–3062
Fisher JP, Young CN, Fadel PJ (2009) Central sympathetic overactivity: maladies and mechanisms. Auton Neurosci 148:5–15
Nowicki M, Zwiech R, Dryja P, Sobanski W (2009) Autonomic neuropathy in hemodialysis patients: questionnaires versus clinical tests. Clin Exp Nephrol 13:152–155
Krishnan AV, Kiernan MC (2007) Uremic neuropathy: clinical features and new pathophysiological insights. Muscle Nerve 35:273–290
DiBona GF (2005) Physiology in perspective: the wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289:R633–R641
Toto R, Palmer BF (2008) Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease. Am J Nephrol 28:372–380
Augustyniak RA, Victor RG, Morgan DA, Zhang W (2006) L-NAME- and ADMA-induced sympathetic neural activation in conscious rats. Am J Physiol Regul Integr Comp Physiol 290:R726–R732
Ksiazek A, Zaluska W (2008) Sympathetic overactivity in uremia. J Ren Nutr 18:118–121
Koomans HA, Blankestijn PJ, Joles JA (2004) Sympathetic hyperactivity in chronic renal failure: a wake-up call. J Am Soc Nephrol 15:524–537
Brotman DJ, Bash LD, Qayyum R et al (2010) Heart rate variability predicts ESRD and CKD-related hospitalization. J Am Soc Nephrol 21:1560–1570
Vanderlei LC, Pastre CM, Hoshi RA, Carvalho TD, Godoy MF (2009) Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc 24:205–217
La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (autonomic tone and reflexes after myocardial infarction) investigators. Lancet 351:478–484
Tsuji H, Larson MG, Venditti FJ Jr et al (1996) Impact of reduced heart rate variability on risk for cardiac events. The Framingham heart study. Circulation 94:2850–2855
Romanowicz M, Schmidt JE, Bostwick JM, Mrazek DA, Karpyak VM (2011) Changes in heart rate variability associated with acute alcohol consumption: current knowledge and implications for practice and research. Alcohol Clin Exp Res 35:1092–1105
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93:1043–65
Fukuta H, Hayano J, Ishihara S et al (2003) Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol Dial Transpl 18:318–325
Chandra P, Sands RL, Gillespie BW et al (2012) Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol Dial Transpl 27(2):700–709
Wen TL, Chung-Kwe W, Yang IF, Yang TF (2007) Relationship between electrolytes and heart rate variability parameters in end-stage renal failure patients before and after hemodialysis. Anadolu Kardiyol Derg 7(Suppl 1):142–144
Furuland H, Linde T, Englund A, Wikstrom B (2008) Heart rate variability is decreased in chronic kidney disease but may improve with hemoglobin normalization. J Nephrol 21:45–52
Psychari SN, Sinos L, Iatrou C, Liakos G, Apostolou TS (2005) Relations of inflammatory markers to lipid levels and autonomic tone in patients with moderate and severe chronic kidney disease and in patients under maintenance hemodialysis. Clin Nephrol 64:419–427
Shoji T, Tsubakihara Y, Fujii M, Imai E (2004) Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 66:1212–1220
Yamamoto K, Kobayashi N, Kutsuna T et al (2012) Excessive fall of blood pressure during maintenance hemodialysis in patients with chronic renal failure is induced by vascular malfunction and imbalance of autonomic nervous activity. Ther Apher Dial 16:219–225
Coquet I, Mousson C, Rifle G et al (2005) Influence of ischemia on heart-rate variability in chronic hemodialysis patients. Ren Fail 27:7–12
Nishimura M, Hashimoto T, Kobayashi H et al (2004) Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients. Nephrol Dial Transplant 19:2532–2538
Deligiannis A, Kouidi E, Tourkantonis A (1999) Effects of physical training on heart rate variability in patients on hemodialysis. Am J Cardiol 84:197–202
Kouidi E, Karagiannis V, Grekas D et al (2010) Depression, heart rate variability, and exercise training in dialysis patients. Eur J Cardiovasc Prev Rehabil 17:160–167
Svensson M, Schmidt EB, Jorgensen KA, Christensen JH (2007) The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis. J Ren Nutr 17:243–249
Tory K, Horvath E, Suveges Z et al (2004) Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial. Clin Nephrol 61:316–323
Rubinger D, Revis N, Pollak A, Luria MH, Sapoznikov D (2004) Predictors of haemodynamic instability and heart rate variability during haemodialysis. Nephrol Dial Transpl 19:2053–2060
Tong YQ, Hou HM (2007) Alteration of heart rate variability parameters in nondiabetic hemodialysis patients. Am J Nephrol 27:63–69
Giordano M, Manzella D, Paolisso G, Caliendo A, Varricchio M, Giordano C (2001) Differences in heart rate variability parameters during the post-dialytic period in type II diabetic and non-diabetic ESRD patients. Nephrol Dial Transpl 16:566–573
Chan CT, Hanly P, Gabor J, Picton P, Pierratos A, Floras JS (2004) Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 65:661–665
Laaksonen S, Voipio-Pulkki L, Erkinjuntti M, Asola M, Falck B (2000) Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uraemia? J Intern Med 248:21–26
Dursun B, Demircioglu F, Varan HI et al (2004) Effects of different dialysis modalities on cardiac autonomic dysfunctions in end-stage renal disease patients: one year prospective study. Ren Fail 26:35–38
Rubinger D, Backenroth R, Sapoznikov D (2009) Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation. Nephrol Dial Transpl 24:1305–1313
Yang YW, Wu CH, Tsai MK, Kuo TB, Yang CC, Lee PH (2010) Heart rate variability during hemodialysis and following renal transplantation. Transpl Proc 42:1637–1640
Acknowledgments
This study was funded by the National Natural Science Foundation of China (81270408), ZX07 200908, RC201162, 2010(IB10), LJ201125, PAPD.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, J., Wang, N. Prognostic significance and therapeutic option of heart rate variability in chronic kidney disease. Int Urol Nephrol 46, 19–25 (2014). https://doi.org/10.1007/s11255-013-0421-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-013-0421-3